The lactate/SIRT3/AMPK pathway, by inhibiting aerobic glycolysis, alleviates sepsis-induced kidney injury, indicating a potential reclassification of lactate from a “metabolic waste” to a therapeutic target for organ damage in sepsis. This evidence concerns the gene SIRT3 and Sepsis.